




Searching News Database: Vidaza
HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
HSMN NewsFeed - 21 Aug 2008
VIDAZA(R) Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS
VIDAZA(R) Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS
HSMN NewsFeed - 7 Aug 2008
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
HSMN NewsFeed - 13 Jun 2008
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
HSMN NewsFeed - 17 Oct 2007
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
HSMN NewsFeed - 2 Jun 2007
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
HSMN NewsFeed - 22 Mar 2007
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
HSMN NewsFeed - 29 Jan 2007
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
HSMN NewsFeed - 11 Dec 2006
New Data Validate Vidaza(R) Response Rates in MDS and Report Results in AML
New Data Validate Vidaza(R) Response Rates in MDS and Report Results in AML
HSMN NewsFeed - 21 Nov 2006
Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
HSMN NewsFeed - 1 Nov 2006
Pharmion Corporation Announces Enrollment of First Patient Into Vidaza(R) Patient Registry
Pharmion Corporation Announces Enrollment of First Patient Into Vidaza(R) Patient Registry
Additional items found! 14

Members Archive contains
14 additional stories matching:
Vidaza
(Password required)
Vidaza
(Password required)